200 related articles for article (PubMed ID: 29245350)
1. A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia.
Wu X; Zhao P; Dong L; Zhang X
Medicine (Baltimore); 2017 Dec; 96(49):e9124. PubMed ID: 29245350
[TBL] [Abstract][Full Text] [Related]
2. Hypofibrinogenemia induced by tigecycline: a potentially life-threatening coagulation disorder.
Sabanis N; Paschou E; Gavriilaki E; Kalaitzoglou A; Vasileiou S
Infect Dis (Lond); 2015; 47(10):743-6. PubMed ID: 25951751
[TBL] [Abstract][Full Text] [Related]
3. Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.
Fan Q; Huang W; Weng Y; Xie X; Shi Z
Medicine (Baltimore); 2020 Oct; 99(43):e22638. PubMed ID: 33120753
[TBL] [Abstract][Full Text] [Related]
4. Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline.
Pieringer H; Schmekal B; Biesenbach G; Pohanka E
Ann Hematol; 2010 Oct; 89(10):1063-4. PubMed ID: 20174923
[No Abstract] [Full Text] [Related]
5. Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia.
Lei H; Liu X; Li Z; Wang C
J Chemother; 2023 Jul; 35(4):292-297. PubMed ID: 35904191
[TBL] [Abstract][Full Text] [Related]
6. Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis.
Rossitto G; Piano S; Rosi S; Simioni P; Angeli P
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):681-4. PubMed ID: 24667348
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline-induced coagulopathy.
McMahan J; Moenster RP
Am J Health Syst Pharm; 2017 Feb; 74(3):130-134. PubMed ID: 28122754
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for tigecycline-induced hypofibrinogenaemia.
Zhang Q; Wang J; Liu H; Ma W; Zhou S; Zhou J
J Clin Pharm Ther; 2020 Dec; 45(6):1434-1441. PubMed ID: 32860258
[TBL] [Abstract][Full Text] [Related]
9. Tigecycline treatment causes a decrease in fibrinogen levels.
Zhang Q; Zhou S; Zhou J
Antimicrob Agents Chemother; 2015 Mar; 59(3):1650-5. PubMed ID: 25547356
[TBL] [Abstract][Full Text] [Related]
10. Tigecycline-induced coagulopathy: a literature review.
Cui N; Cai H; Li Z; Lu Y; Wang G; Lu A
Int J Clin Pharm; 2019 Dec; 41(6):1408-1413. PubMed ID: 31713108
[TBL] [Abstract][Full Text] [Related]
11. Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
Li ZK; Zheng P
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):466-470. PubMed ID: 37548456
[TBL] [Abstract][Full Text] [Related]
12. Tigecycline-associated hypofibrinogenemia in a real-world setting.
Campany-Herrero D; Larrosa-Garcia M; Lalueza-Broto P; Rivera-Sánchez L; Espinosa-Pereiro J; Mestre-Torres J; Pigrau-Serrallach C
Int J Clin Pharm; 2020 Aug; 42(4):1184-1189. PubMed ID: 32504166
[TBL] [Abstract][Full Text] [Related]
13. A Lesser Known Side Effect of Tigecycline: Hypofibrinogenemia.
Yılmaz Duran F; Yıldırım H; Şen EM
Turk J Haematol; 2018 Mar; 35(1):83-84. PubMed ID: 29212626
[No Abstract] [Full Text] [Related]
14. Tigecycline-induced life-threatening coagulopathy in a patient with a Mycobacterium abscess: a case report and step-by-step diagnostic approach.
Akalay S; Vanassche T; De Munter P
Acta Clin Belg; 2021 Oct; 76(5):410-414. PubMed ID: 32255411
[TBL] [Abstract][Full Text] [Related]
15. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
[No Abstract] [Full Text] [Related]
16. Tigecycline-associated hypofibrinogenemia: A single center, retrospective, controlled study.
Firat O; Kara E; Malkan ÜY; Demirkan K; Inkaya AÇ
Thromb Res; 2024 Apr; 236():155-160. PubMed ID: 38452447
[TBL] [Abstract][Full Text] [Related]
17. Severe Coagulation Disorder and Thrombocytopenia Associated with Tigecycline - Case Report and Review of Literature.
Giryes S; Azzam ZS; Ismael-Badarneh R; Krivoy N; Berger G
Curr Drug Saf; 2017; 12(1):7-9. PubMed ID: 27659942
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline-induced acute pancreatitis: case report and literature review.
Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
[TBL] [Abstract][Full Text] [Related]
19. Tigecycline-Associated Coagulopathy: A Single-Center Retrospective Analysis.
Wang D; Lin C; Gu C; Wu Y; Wang S
Pharmacology; 2022; 107(9-10):524-536. PubMed ID: 35820375
[TBL] [Abstract][Full Text] [Related]
20. Incidence, characteristics and risk factors of hypofibrinogenemia associated with tigecycline: A multicenter retrospective study in China.
Leng B; Shen C; Gao T; Zhao K; Zhao X; Guo Y; Wu J; Yang J; Fang W; Zhang J; Zhang Y; Sun C; Duan L; Huang J; Qi Y; Yan G
Front Pharmacol; 2022; 13():943674. PubMed ID: 36304151
[No Abstract] [Full Text] [Related]
[Next] [New Search]
